Business Context and Reporting Period
This Form 6-K filing by Tower Semiconductor Ltd. covers the period ending June 18, 2009. The filing primarily announces a strategic partnership with Crocus Technology to manufacture next-generation Magnetic Random Access Memory (MRAM).
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for Tower Semiconductor Ltd. for the reporting period. The only specific financial value disclosed is the equity investment made by Tower in Crocus Technology, valued at $1.25 million.
Material Changes
- Strategic Partnership: Tower Semiconductor has entered an exclusive agreement to port Crocus Technology's MRAM process into Tower's 200mm Fab2 facility.
- Manufacturing Commitment: Tower will perform all manufacturing steps for Crocus's next-generation MRAM technology and has dedicated specific equipment in its factory to this production.
- Equity Investment: Tower has taken an equity position in Crocus Technology valued at $1.25 million.
Outlook, Commentary, and Risks
Management Commentary: Tower's management views MRAM as having "industry-changing potential" and a "high volume market with a long life." The partnership is expected to enable the rapid commercialization of MRAM products for microcontrollers, automotive, and communications sectors.
Market Outlook: According to Web-Feet Research, Crocus's technology could capture a portion of the $700 million NOR cellular and networking market by 2011. Embedded MRAM targets integrated memory components in SOC and ASIC markets, representing over $10 billion in semiconductor revenues.
Risks and Contingencies: The filing includes a Safe Harbor statement regarding forward-looking statements. Actual results may vary due to risks and uncertainties detailed in Tower's most recent Forms 20-F, F-3, F-4, and 6-K, as well as Jazz Semiconductor's Forms 10-K and 10-Q. Tower disclaims any obligation to update the information in this release.
Investor Verification Checklist
- Verify the specific terms and duration of the exclusive manufacturing agreement with Crocus Technology.
- Confirm the impact of the $1.25 million equity investment on Tower's balance sheet and future earnings.
- Review the "Risk Factors" section in Tower's most recent Form 20-F for details on technology adoption risks and market competition.
- Assess the timeline for the transition from Crocus's test vehicles to full commercial volume production.
- Monitor the allocation of specific equipment at Fab2 and its impact on capacity for other specialty foundry customers.